(19)
(11) EP 1 176 978 A2

(12)

(88) Date of publication A3:
26.04.2001

(43) Date of publication:
06.02.2002 Bulletin 2002/06

(21) Application number: 00932163.9

(22) Date of filing: 05.05.2000
(51) International Patent Classification (IPC)7A61K 39/21, A61K 39/39, A61P 31/18
(86) International application number:
PCT/US0012/495
(87) International publication number:
WO 0067/787 (16.11.2000 Gazette 2000/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.05.1999 US 132762 P
25.08.1999 US 150667 P

(71) Applicant: THE IMMUNE RESPONSE CORPORATION
Carlsbad, CA 92008 (US)

(72) Inventor:
  • MOSS, Ronald, B.
    San Diego, CA 92130 (US)

(74) Representative: UEXKÜLL & STOLBERG 
Patentanwälte Beselerstrasse 4
22607 Hamburg
22607 Hamburg (DE)

   


(54) HIV IMMUNOGENIC COMPOSITIONS AND METHODS